A former drug addict said that ketamine should be a Class A drug as data revealed the number of people being treated in ...

In January 2022, the U.S. Food and Drug Administration (FDA) released finalized guidance on premarket pathways for combination products. While the guidance is not binding, it provides industry ...

The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that ...

The vision of precision oncology entails a shift toward (semi)automated, data-driven workflows that guide treatment on the basis of an individual patient's clinical and molecular profile and leverage ...